CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 94 filers reported holding CTI BIOPHARMA CORP in Q4 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $14,000 | -51.7% | 10,000 | -33.3% | 0.00% | -40.0% |
Q2 2015 | $29,000 | -21.6% | 15,000 | -28.2% | 0.01% | -28.6% |
Q1 2015 | $37,000 | +8.8% | 20,900 | +42.2% | 0.01% | +16.7% |
Q4 2014 | $34,000 | -17.1% | 14,700 | -13.3% | 0.01% | -25.0% |
Q3 2014 | $41,000 | -8.9% | 16,950 | +3.7% | 0.01% | +14.3% |
Q2 2014 | $45,000 | – | 16,350 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EAGLE ASSET MANAGEMENT INC | 15,707,022 | $38,010,000 | 0.11% |
First Heartland Consultants, Inc. | 74,624 | $181,000 | 0.08% |
WASHINGTON TRUST Co | 410,616 | $994,000 | 0.07% |
Geduld E E | 40,000 | $97,000 | 0.07% |
FIRST NEW YORK SECURITIES LLC /NY | 30,562 | $73,960,000 | 0.05% |
Crosspoint Capital Strategies, LLC | 25,000 | $61,000 | 0.04% |
JANE STREET GROUP, LLC | 1,434,975 | $3,473,000 | 0.04% |
MAGEE THOMSON INVESTMENT PARTNERS LLC | 21,479 | $51,000 | 0.01% |
TIAA CREF TRUST CO FSB/MO | 296,322 | $717,000 | 0.01% |
Investors Capital Advisory Services | 16,950 | $41,000 | 0.01% |